𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD4+, HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells

✍ Scribed by Rajasekharan Somasundaram; Paul Robbins; Dilip Moonka; Elwyn Loh; Francesco Marincola; Amy Patel; DuPont Guerry; Dorothee Herlyn

Book ID
101236195
Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
93 KB
Volume
85
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A CD4+, HLA-DR7-restricted T-helper lymp
A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma
✍ Rajasekharan Somasundaram; Rolf Swoboda; Laura Caputo; Allana Lee; Naidine Jacks πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 123 KB

## Abstract CD4^+^ Th cells that are restricted by MHC class II molecules play an important role in the induction of antitumor immune responses. We have established a stable CD4^+^ Th cell clone (Th35‐1A) from the PBMCs of a patient with primary cutaneous melanoma. The Th cell clone is noncytolytic

MHC class-I-restricted auto-tumor-specif
MHC class-I-restricted auto-tumor-specific CD4+CD8 βˆ’T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC)
✍ P. Wang; F. VΓ nky; E. Klein πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 670 KB

Autologous mixed lymphocyte-tumor cell cultures (MLTC) were initiated with cytokine (IFNy and TNFa)-treated ex-vivo tumor cells of lung, ovarian, breast and stomach carcinomas. The cytokine-treated tumors expressed class-I but not class-ll molecules. Although the proportion of CD8+ lymphocytes incre